Vanguard Global Advisers’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Sell
101,713
-179,401
-64% -$2.15M ﹤0.01% 1538
2026
Q1
$1.68M Buy
+281,114
New +$2.12M ﹤0.01% 1308

Other funds holding OGN

Vanguard Global Advisers's OGN Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Organon & Co (OGN) stake by 64% in Q2 2026, selling an estimated $2.15M and leaving 101,713 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

Vanguard Global Advisers first reported a position in OGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.68M in Q1 2026. 622 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Vanguard Global Advisers held 101,713 shares of Organon & Co worth $1.38M as of Q2 2026.
  • Vanguard Global Advisers sold 179,401 Organon & Co shares in Q2 2026, an estimated $2.15M.
  • Organon & Co made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1538 holding.
  • Vanguard Global Advisers first reported a position in Organon & Co in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Organon & Co position peaked at $1.68M in Q1 2026.
  • 622 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.